Related Experiment Video
Updated: Jun 19, 2026
10:47
Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
SULFONAMIDE CHEMOTHERAPY OF COMBINED INFECTION WITH INFLUENZA VIRUS AND BACTERIA
C G Harford1, M R Smith, W B Wood
1Department of Internal Medicine, Washington University School of Medicine and the Oscar Johnson Institute for Medical Research, St. Louis.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Sulfonamide chemotherapy effectively treats secondary bacterial pneumonia in mice infected with influenza virus. This treatment is crucial for managing combined viral and bacterial respiratory infections, potentially lowering mortality rates during influenza pandemics.
Area of Science:
- Microbiology
- Virology
- Pharmacology
Background:
- Viral infections like influenza can increase susceptibility to secondary bacterial pneumonia.
- The interplay between viral and bacterial pathogens in respiratory infections is complex and can lead to severe outcomes.
- Understanding the efficacy of antimicrobial agents in treating such polymicrobial infections is critical.
Purpose of the Study:
- To investigate the effectiveness of sulfonamide chemotherapy in controlling bacterial infections secondary to viral pneumonia.
- To determine if sulfonamide treatment can mitigate the severity of combined influenza virus and bacterial infections.
- To assess the potential role of sulfonamide chemotherapy in managing influenza-associated bacterial pneumonia.
Main Methods:
- Induction of combined influenza virus and bacterial infections in rodent models (rats and mice).
- Administration of sulfonamide chemotherapy to treat bacterial components of the infection.
- Evaluation of infection lethality and disease progression following viral and bacterial co-infection.
Main Results:
- Sulfonamide chemotherapy successfully controlled the bacterial component in combined influenza virus and pneumococcal infections in rats.
- In mice, secondary bacterial pneumonia superimposed on sublethal viral infection was controlled by sulfonamide chemotherapy.
- The study demonstrated that secondary bacterial pneumonia did not invariably convert a sublethal viral infection into a lethal one when treated.
Conclusions:
- Sulfonamide chemotherapy is a valuable treatment for bacterial pneumonia complicating influenza virus infections.
- This therapy can effectively manage the bacterial component of polymicrobial respiratory infections.
- Sulfonamide chemotherapy holds promise for reducing case fatality rates during influenza pandemics, particularly when the viral component is not overwhelmingly severe.
More Related Videos
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: